108 related articles for article (PubMed ID: 12972998)
1. F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
Hurwitz R
Clin Nucl Med; 2003 Sep; 28(9):755-6. PubMed ID: 12972998
[TBL] [Abstract][Full Text] [Related]
2. Extracapsular breast implant rupture mimicking local cancer recurrence on
Domínguez ML; Salvat C; F-Llana B; Vigil C; Suárez JP; González FM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):392-394. PubMed ID: 30031678
[No Abstract] [Full Text] [Related]
3. Breast implant foreign body reaction mimicking breast cancer recurrence on FDG PET/CT.
Ulaner GA; D'Andrea G; Cody HS
Clin Nucl Med; 2013 Jun; 38(6):480-1. PubMed ID: 23640240
[TBL] [Abstract][Full Text] [Related]
4. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
5. Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
Mathew AS; El-Haddad G; Lilien DL; Takalkar AM
Clin Nucl Med; 2008 May; 33(5):330-2. PubMed ID: 18431146
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Eubank WB
Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory F-18 FDG uptake secondary to ruptured breast prosthesis.
Bhargava P; Glass E; Ghesani M
Clin Nucl Med; 2006 Apr; 31(4):227-8. PubMed ID: 16550024
[TBL] [Abstract][Full Text] [Related]
8. F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Bakheet SM; Powe J; Ezzat A; Al Suhaibani H; Tulbah A; Rostom A
Clin Nucl Med; 1998 Sep; 23(9):604-8. PubMed ID: 9735983
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
Suárez M; Pérez-Castejón MJ; Jiménez A; Domper M; Ruiz G; Montz R; Carreras JL
Q J Nucl Med; 2002 Jun; 46(2):113-21. PubMed ID: 12114874
[TBL] [Abstract][Full Text] [Related]
10. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
[TBL] [Abstract][Full Text] [Related]
11. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
[TBL] [Abstract][Full Text] [Related]
12. A Case of Adenomyoepithelioma of the Breast Showing Strong Uptake of
Oba T; Maeno K; Ono M; Iesato A; Ito T; Kanai T; Mochizuki Y; Ito KI; Yoshizawa A; Takayama F
Breast J; 2017 Mar; 23(2):220-224. PubMed ID: 28299890
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
[TBL] [Abstract][Full Text] [Related]
14.
Palot Manzil FF; Bhambhvani PG
J Nucl Med Technol; 2018 Dec; 46(4):394-395. PubMed ID: 30076249
[No Abstract] [Full Text] [Related]
15. Fluorodeoxyglucose-PET in the management of breast cancer.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
[TBL] [Abstract][Full Text] [Related]
16. [FDG (18 fluorodeoxyglucose) positron emission tomography and breast cancer].
Rouëssé J; Alberini JL; Wartski M; Gutman F; Collignon MA; Corone C; Pichon MF; Pecking AP
Bull Acad Natl Med; 2005 May; 189(5):963-75; discussion 975-8. PubMed ID: 16433466
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET and beyond: molecular breast cancer imaging.
Quon A; Gambhir SS
J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
[No Abstract] [Full Text] [Related]
18. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Landheer ML; Steffens MG; Klinkenbijl JH; Westenberg AH; Oyen WJ
Br J Surg; 2005 Nov; 92(11):1363-7. PubMed ID: 16187254
[TBL] [Abstract][Full Text] [Related]
19. The distinctive role of positron emission tomography/computed tomography in breast carcinoma with brown adipose tissue 2-fluoro-2-deoxy-d-glucose uptake.
Heiba SI; Bernik S; Raphael B; Sandella N; Cholewinski W; Klein P
Breast J; 2005; 11(6):457-61. PubMed ID: 16297092
[TBL] [Abstract][Full Text] [Related]
20. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
